Commitments and Contingencies - Additional Information (Details) - USD ($)	6 Months Ended	12 Months Ended
	Oct. 31, 2024	Apr. 30, 2013	May 06, 2024	Apr. 30, 2024
Loss Contingencies [Line Items]
Lessee, operating lease, option to extend	On September 27, 2022, the Company entered into the First Amendment to Lease (the “Lease Amendment”), which amended the Lease Agreement to document the exercise of its option to extend the term of the lease for an additional 64 months, commencing February 1, 2023, and expiring on May 31, 2028 (the “Extension Term”). Pursuant to the amendment, the Company will pay initial monthly payments of $13,129, beginning February 2023, subject to 3% annual increases.
Operating lease percentage of annual increase	3.00%
Operating lease commencing date	Feb. 01, 2023
Operating lease expiring date	May 31, 2028
Operating lease option to extend additional lease term	64 months
Initial monthly payments	$ 13,129
Rent expense	$ 74,000
Operating lease incremental borrowing rate	12.00%
Common stock, par value	$ 0.001		$ 0.001	$ 0.001
Royalty Agreements
Loss Contingencies [Line Items]
Royalty not paid balance amount		$ 3,500,000
Royalties total amount		$ 3,500,000
Common stock, par value		$ 6,875
Receipt of bona fide offer valuing common stock		$ 6,875
Aggregate payment of royalties		3,000,000
Royalty Agreements | MyoVista Devices
Loss Contingencies [Line Items]
Royalty payment upon paid for each device amount		200
Royalty Agreements | 2,400 MyoVista Devices
Loss Contingencies [Line Items]
Royalty payment upon paid for each device amount		$ 500